PRECISION INHALATION. ENGINEERED FOR MEDICINE.
Alveon has developed the Smart Dose Vaporisation (SDV) platform —
a patented ceramic dosing technology for the metered-dose inhalation of phytopharmaceutical active ingredients, engineered to EU MDR Class II standards.
TECHNOLOGY
A precision inhalation platform built for pharmaceutical-grade therapeutics.
The Alveon SDV platform delivers exact, metered doses of plant-based active ingredients through a certified medical device, combining overdose protection with optimised pulmonary delivery.
Developed by inhalation industry experts and aerospace engineers, the platform is substance-agnostic and designed for licensing across multiple therapeutic areas.
​Core Patents
Filed with the German Patent and Trade Mark Office (DPMA)
EU MDR Class II
Platform development is aligned with the EU Medical Device Regulation Class IIa certification pathway
5+ Years of Development
Combining inhalation industry expertise with aerospace-grade precision manufacturing
An easy-to-use and precise solution for standardised therapy with phytopharmaceuticals and bio-based medicines
Building on extensive market knowhow and a unique technological approach,
we solve existing core challenges:
RELIABLE DOSING
Metered-dose precision ensures consistent active ingredient delivery across every inhalation cycle, providing the reproducibility required for evidence-based treatment protocols.
OVERDOSE PROTECTION
Integrated safety mechanisms are engineered to pharmaceutical device standards, enabling controlled and reproducible therapeutic dosing.
OPTIMIZED DELIVERY
Ceramic vaporisation technology maximises the bioavailability of inhaled active ingredients by optimising particle size distribution and aerosol characteristics for efficient pulmonary absorption.
APPLICATION
First application: The European market for medical cannabis.
Alveon's first commercial product is currently being developed through Alvify GmbH, a joint venture with Canify AG, one of Europe's leading medical cannabis companies.
The device brings the Alveon SDV platform to the European market, targeting pharmacy distribution in Germany and across the EU.
GERMAN MINISTRY OF ECONOMICS
Initial Project Funding
LIFE SCIENCE ACCELERATOR BADEN-WÜRTTEMBERG
12mo accelerator program